Katerina Leftheris, Ph.D., brings over 20 years of small molecule drug discovery and development experience to the company, primarily in immunology, oncology, metabolic disease and neurodegeneration. Previously, Dr. Leftheris was site-head of Discovery Chemistry for Celgene, San Diego, where she led the chemistry team in advancing five novel clinical candidates in immunology and oncology. Prior to joining Celgene, Dr. Leftheris was the Senior Director of Vitae Pharmaceuticals where she expanded the chemistry team and led several small molecule programs in the metabolic disease area. Earlier in her career, Dr. Leftheris held positions of increasing responsibility in Discovery Chemistry at Bristol-Myers Squibb. Dr. Leftheris has over 110 publications and issued patents.
Dr. Leftheris received her B.A. in chemistry from Smith College, Ph.D. in organic chemistry from the University of California, San Diego and completed postdoctoral studies at the University of Pennsylvania.